Focuses and supplements
Nature Biotechnology periodically publishes special supplements and focuses on timely topics of particular interest. This page provides an index of the different supplements and focuses that we have released over the past few years.
Top of page
2007
Antivirals -
This issue provides several articles focusing on antiviral therapy. Additional material, brought together in a joint focus with Nature Reviews Drug Discovery supported by our principal sponsor Pfizer and our supporting sponsor Gilead.
December Vol. 25, No. 12
Top of page
2006
Antibacterials -
A collection of articles from Nature Biotechnology, brought together in a joint focus with Nature Reviews Drug Discovery, on the science and business of antibacterial discovery and development.
December Vol. 24, No. 12
MAQC Consortium -
This supplement collects together reprints of papers from
Nature Biotechnology reporting the first formal results of a consortium of over 150 regulatory, industrial and academic scientists that set out to conduct a cross-platform analysis of DNA microarray expression data obtained from two, commercially available RNA samples.
October Vol. 24, No. 10s
Microarray Quality Control -
The first formal results of a consortium of over 150 regulatory, industrial and academic scientists that set out to conduct a cross-platform analysis of DNA microarray expression data obtained from two, commercially available RNA samples.
September Vol. 24, No. 9
Diagnostics -
A series of articles that focuses on the scientific, business, regulatory, intellectual property, technology transfer and logistical challenges of accelerating integration of molecular diagnostics into clinical practice and therapy selection.
August Vol. 24, No. 8
10th Anniversary -
A focus celebrating 10 years of serving the biotech community.
March Vol. 24, No. 3
Top of page
2005
Antibody Engineering and Manufacture -
A focus examining recent progress in antibody research and the commercial and regulatory developments that are shaping it.
September Vol. 23, No. 9
Cell Therapies -
A focus examining the scientific, legal, regulatory, and commercial context of current cell research for regenerative medicine.
July Vol. 23, No. 7
Top of page
2004
Health Biotechnology Innovation in Developing Countries -
The Health Biotechnology Innovation in Developing Countries supplement presents the results of an in-depth study of the health biotechnology sector of seven developing nations. It demonstrates how poorer nations can successfully exploit the biotechnology sector to build their own wealth and improve the well being of their own people. The study is the brainchild of a group of researchers at the Canadian Program on Genomic and Global Health at the University of Toronto Joint Centre for Bioethics.
December Vol. 22, Issue 12s
Biomanufacturing and Bioprocessing -
As more biotech products receive regulatory approval and the first protein blockbusters come off patent and face generic competition, this focus discusses the challenges for companies manufacturing recombinant proteins.
November Vol. 22, No. 11
Systems biology -
A series of articles focuses on potential applications of systems biology to biotechnology.
October Vol. 22, No. 10
Top of page
2003
Optical imaging -
Brings together a selection of articles on new techniques in optical imaging.
November Vol. 21, No. 11
Nanobiotechnology -
Looks at some of the emerging life science applications of nanotechnology and nanoscience.
October Vol. 21, No. 10
Challenges in proteomics -
Examines the status of technologies for quantitative protein analysis and the challenges facing efforts to catalogue and characterize the protein content of cells.
March Vol. 21, No. 3
Top of page
2002
Environmental impact of GM crops -
Investigates the environmental consequences of cross-fertilization and pollen transfer between GM crops and sexually compatible relatives.
June Vol. 20, No. 6
Top of page
2000
Industry Trends -
Industry Trends supplement is a collection of both original and updated previously published articles from Aris Persidis' Industry Trends column, which has been published on a regular basis in Nature Biotechnology from 1997 to 1999. Each article provides a concise summary of the historical evolution, current state, challenges, and possible future directions of a biotechnology field. As a collection, the articles provide concise snapshots of biotechnology's fastest-moving areas in a format that allows easy comparison.
October Vol. 18, Issue 10s
Top of page
1999
BioVision -
The Nature Biotechnology BioVision supplement contains a diverse set of articles that discuss the potential of biotechnology for improving the quality and duration of life in the coming millennium. Concomitant with the first BioVision meeting in Lyon, France, March 26-29, 1999, the supplement provides a forum for leaders in science, business, and social and cultural thinking to debate the importance of biotechnology in addressing global issues such as population growth, human health, the environment, and their societal, cultural, and political repercussions.
February Vol. 17, Issue 2s
Top of page
1998
Pharmacogenomics -
The Nature Biotechnology Pharmacogenomics Supplement brings together articles exploring the importance of genetic variation in drug development that have previously been published in the journal. It captures the excitement surrounding this field, presents the rationale behind diagnostic-led treatment, and outlines the commercial opportunities attendant with the move toward individualized medicine.
FebruaryVol. 16, Issue 2s